LV12734B - USE OF PIPERAZINE DERIVATIVES FOR TREATMENT OF TROUBLESHOOTING - Google Patents
USE OF PIPERAZINE DERIVATIVES FOR TREATMENT OF TROUBLESHOOTING Download PDFInfo
- Publication number
- LV12734B LV12734B LVP-01-102A LV010102A LV12734B LV 12734 B LV12734 B LV 12734B LV 010102 A LV010102 A LV 010102A LV 12734 B LV12734 B LV 12734B
- Authority
- LV
- Latvia
- Prior art keywords
- alkyl
- aryl
- cycloalkyl
- hydrogen
- radical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929223153A GB9223153D0 (en) | 1992-11-05 | 1992-11-05 | Piperazine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
LV12734A LV12734A (en) | 2001-10-20 |
LV12734B true LV12734B (en) | 2002-01-20 |
Family
ID=10724559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-01-102A LV12734B (en) | 1992-11-05 | 2001-07-04 | USE OF PIPERAZINE DERIVATIVES FOR TREATMENT OF TROUBLESHOOTING |
Country Status (18)
Country | Link |
---|---|
US (1) | US5827847A (es) |
EP (1) | EP0877612B1 (es) |
JP (1) | JP3238153B2 (es) |
AT (1) | ATE195422T1 (es) |
AU (1) | AU682155B2 (es) |
CA (1) | CA2148593C (es) |
DE (1) | DE69329252T2 (es) |
DK (1) | DK0877612T3 (es) |
ES (1) | ES2149216T3 (es) |
GB (1) | GB9223153D0 (es) |
GR (1) | GR3034400T3 (es) |
HU (1) | HUT72049A (es) |
LV (1) | LV12734B (es) |
MX (1) | MX9306879A (es) |
PT (1) | PT877612E (es) |
TW (1) | TW252043B (es) |
WO (1) | WO1994009780A1 (es) |
ZA (1) | ZA937827B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0710481A1 (en) * | 1994-11-02 | 1996-05-08 | Duphar International Research B.V | Use of flesinoxan for cognition enhancement |
US6271234B1 (en) * | 1997-08-01 | 2001-08-07 | Recordati S.A., Chemical And Pharmaceutical Company | 1,4-disubstituted piperazines |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2355502A1 (fr) * | 1976-06-23 | 1978-01-20 | Roussel Uclaf | Application a titre de medicaments d'un derive de la piperazine et de ses sels |
US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
GB2222768B (en) * | 1988-06-17 | 1992-01-22 | Nat Res Dev | Analgesic compounds and compositions |
GB8909209D0 (en) * | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
US4902687A (en) * | 1989-03-27 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
PT93824B (pt) * | 1989-04-22 | 1996-09-30 | Wyeth John & Brother Ltd | Processo para a preparacao de derivados de piperazina |
IE950248L (en) * | 1989-04-22 | 1990-10-22 | Wyeth John & Brother Ltd | Piperazine derivatives |
EP0398413A1 (en) * | 1989-05-16 | 1990-11-22 | Duphar International Research B.V | "3,4-dehydropiperidine derivatives having psychotropic activity |
JP3049089B2 (ja) * | 1990-01-11 | 2000-06-05 | ファルマシア・アンド・アップジョン・カンパニー | 新規な中枢作用性の6,7,8,9―テトラヒドロ―3H―ベンズ[e]インドールヘテロ環式化合物 |
GB9022820D0 (en) * | 1990-10-19 | 1990-12-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
DE4039631A1 (de) * | 1990-12-12 | 1992-06-17 | Troponwerke Gmbh & Co Kg | Neuroprotektive kombination |
AU645681B2 (en) * | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
DE4135551A1 (de) * | 1991-08-31 | 1993-03-04 | Schering Ag | Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen |
-
1992
- 1992-11-05 GB GB929223153A patent/GB9223153D0/en active Pending
-
1993
- 1993-10-21 ZA ZA937827A patent/ZA937827B/xx unknown
- 1993-10-25 US US08/428,093 patent/US5827847A/en not_active Expired - Fee Related
- 1993-10-25 CA CA002148593A patent/CA2148593C/en not_active Expired - Fee Related
- 1993-10-25 ES ES93923615T patent/ES2149216T3/es not_active Expired - Lifetime
- 1993-10-25 DK DK93923615T patent/DK0877612T3/da active
- 1993-10-25 JP JP51081394A patent/JP3238153B2/ja not_active Expired - Fee Related
- 1993-10-25 DE DE69329252T patent/DE69329252T2/de not_active Expired - Fee Related
- 1993-10-25 EP EP93923615A patent/EP0877612B1/en not_active Expired - Lifetime
- 1993-10-25 WO PCT/GB1993/002197 patent/WO1994009780A1/en active IP Right Grant
- 1993-10-25 PT PT93923615T patent/PT877612E/pt unknown
- 1993-10-25 HU HU9501290A patent/HUT72049A/hu unknown
- 1993-10-25 AT AT93923615T patent/ATE195422T1/de not_active IP Right Cessation
- 1993-10-25 AU AU53421/94A patent/AU682155B2/en not_active Ceased
- 1993-10-26 TW TW082108882A patent/TW252043B/zh active
- 1993-11-04 MX MX9306879A patent/MX9306879A/es not_active IP Right Cessation
-
2000
- 2000-09-13 GR GR20000402090T patent/GR3034400T3/el not_active IP Right Cessation
-
2001
- 2001-07-04 LV LVP-01-102A patent/LV12734B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US5827847A (en) | 1998-10-27 |
PT877612E (pt) | 2000-11-30 |
MX9306879A (es) | 1995-01-31 |
WO1994009780A1 (en) | 1994-05-11 |
AU5342194A (en) | 1994-05-24 |
DE69329252D1 (de) | 2000-09-21 |
TW252043B (es) | 1995-07-21 |
LV12734A (en) | 2001-10-20 |
HU9501290D0 (en) | 1995-06-28 |
EP0877612B1 (en) | 2000-08-16 |
DK0877612T3 (da) | 2000-10-09 |
JPH08502743A (ja) | 1996-03-26 |
CA2148593C (en) | 2005-12-06 |
CA2148593A1 (en) | 1994-05-11 |
ZA937827B (en) | 1995-04-21 |
EP0877612A1 (en) | 1998-11-18 |
ATE195422T1 (de) | 2000-09-15 |
GB9223153D0 (en) | 1992-12-16 |
ES2149216T3 (es) | 2000-11-01 |
AU682155B2 (en) | 1997-09-25 |
HUT72049A (en) | 1996-03-28 |
DE69329252T2 (de) | 2001-03-29 |
GR3034400T3 (en) | 2000-12-29 |
JP3238153B2 (ja) | 2001-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU703350B2 (en) | Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands | |
US6656943B2 (en) | 1-phenyl-4-benzlpiperazines: dopamine receptor subtype specific ligands | |
FI73986C (fi) | Analogifoerfarande foer framstaellning av 1-piperazinkarboxamider. | |
WO1998006717A1 (en) | Fused indolecarboxamides: dopamine receptor subtype specific ligands | |
US3262852A (en) | Vasodilator and anti-anginose com- pounds containing methoxy benzyl piperazines and method of using the same | |
CA2443636C (en) | Remedial agent for chronic articular rheumatism | |
US4507318A (en) | 1-Aryl 2-aminomethyl cyclopropane carboxylates (Z) as drugs in the treatment of pain | |
PL144921B1 (en) | Method of obtaining novel susbtituted pyrolidinone | |
US3459757A (en) | Imidazolidines | |
LV12734B (en) | USE OF PIPERAZINE DERIVATIVES FOR TREATMENT OF TROUBLESHOOTING | |
CN102796121B (zh) | 3-芳基-7H-噻唑并[3,2-b]-1,2,4-三嗪-7-酮类衍生物及其应用 | |
US3155584A (en) | Compositions and method of inhibiting monoamine oxidase and treating hypertension | |
GB2272155A (en) | Piperazine derivatives for treatment of cognitive disorders | |
US3089819A (en) | Method for the treatment of hypertension | |
US4656175A (en) | Method of treating aggressive behavior and psychotic conditions employing 1-piperazinocarboxylates | |
US3891648A (en) | 2-{8 (1,4-Benzodioxan)-2-yl{9 -acetamidines | |
JPH037229A (ja) | 脳神経機能改善剤 | |
JP3681770B2 (ja) | 老年性痴呆症又はアルツハイマー病治療剤 | |
GB2307858A (en) | Compositions containing piperazine derivatives for the treatment of cancer | |
MXPA98008541A (es) | N-aminoalquil-2-antraquinoncarboxamidas;nuevos ligandos especificos del subtipo del receptor de dopamina | |
EP0171912A1 (en) | Pyrrolizidine compounds, methods for their production, and their uses | |
AMIDES | Leblond et a1.(45) Date of Patent: Jan. 6, 2015 |